AnalysisNews

PBH today

$45.07+$0.90 (+2.04%)close Nov 12, 2026

Trend

DailyDowntrend (confirmed)

4 hourExpanding

1 hourLeaning Bullish

15 minStrong Bullish

5 minStrong Bullish

Daily trend turns up above $55.99

Key levels

Resistance$50.84

Resistance$46.47

Support$41.77

Support$39.44

Latest news & SEC filings

AnalystCanaccord Genuity keeps Buy rating on Prestige Consumer, cuts target to $70

EarningsPremium Brands Holdings posts Q3 2026 results

EarningsPrestige Consumer holds Q2 2027 earnings call

EarningsPrestige Consumer Healthcare posts fiscal 2027 second quarter results

All PBH news →

About Prestige Consumer Healthcare

Prestige Consumer Healthcare is a consumer packaged goods company that owns and markets brand-name over-the-counter healthcare and personal care products. Its portfolio spans categories such as eye care, gastrointestinal, oral care, pain relief, and women's health, sold under well-known brand names. The company sells primarily through retailers including mass merchandisers, drugstores, supermarkets, convenience stores, and e-commerce platforms, with Walmart and Amazon among its largest customers. It operates in the United States, Canada, Australia, and other international markets, and also runs several manufacturing facilities.

Based on the company's 10-K filed May 14, 2026.

NYSE · Healthcare

Prestige Consumer Healthcare Inc. (PBH)

$45.07+0.90 (+2.04%)
WATCHLISTGrade: C+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
45.0447.1049.1651.2245.07Oct 12Oct 20Oct 28Nov 5
High45.25
Low44.01
Open44.72
Volume127K
Avg Vol538K
VWAP44.79
30d High53.28
30d Low42.98
30d Chg-0.42%

What Is the Price Target for PBH?

SEPT Low Target

$65.00

SEPT Mid Target

$68.50

SEPT High Target

$72.00

Analyst Consensus

$68.50

Current: $43.69Upside: +56.8%Confidence: 40%Method: Analyst Consensus

Is PBH a Buy or Sell Right Now?

49
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Critical news
Nov 5HIGHEarnings: growth/beat

Thesis

  • •Revenue growing -4.3% YoY with DECLINING trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PBH.

Start Free Trial →

Is PBH Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/E Forward, P/B, Analyst Consensus

Fair Value

$77.09

39

Moat Score

NONE

5/9

Piotroski Score

2.3

Altman Z-Score

What Is Smart Money Doing with PBH?

Insider Signal

NEUTRAL

0 buys / 2 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

PBH Growth Story

Revenue YoY

-4.3%

3yr Revenue CAGR

-1.2%

EPS Growth YoY

-8.86%

FCF Growth YoY

1.3%

Revenue Trend

DECLINING

Dark Pool Trades for PBH

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for PBH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
16:28:13$44.981,847$$83KBUY
16:27:07$45.061,883$$85KBUY
16:18:01$44.801,064$$48KBUY
16:03:01$44.281,227$$54KSELL
15:58:33$44.341,115$$49KSELL

5 dark pool trades shown · $$319K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Prestige Consumer Healthcare Inc. (PBH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

PBH — frequently asked questions

What is PBH stock price today?

Prestige Consumer Healthcare Inc. (PBH) is at $45.07, up 2.04% (+$0.90) at the Nov 12, 2026 close.

Why is PBH stock moving today?

Latest PBH news — Nov 6, 2026: Canaccord Genuity keeps Buy rating on Prestige Consumer, cuts target to $70 · Nov 5, 2026: Premium Brands Holdings posts Q3 2026 results

What is the PBH price target?

The average analyst price target for PBH is $68.50, ranging from $65 to $72, based on 2 analysts. Latest: Canaccord Genuity maintains on May 15, 2026.

What do analysts rate PBH?

Analyst ratings for PBH: 0 Buy, 2 Hold, 1 Sell — consensus Hold.

Did PBH beat earnings?

PBH last reported on Aug 6, 2026: EPS $0.98 vs $0.89 expected — a beat of 10.1%.

What is PBH's P/E ratio?

PBH trades at a P/E of 14.9 vs a Healthcare average of 18.5.

Does PBH pay a dividend?

PBH does not currently pay a dividend.

What are PBH support and resistance levels?

Support: $41.77, $39.44, $37.07. Resistance: $46.47, $50.84, $53.35.

What are insiders doing with PBH?

Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.

What is the latest news on PBH?

Nov 6, 2026: Canaccord Genuity keeps Buy rating on Prestige Consumer, cuts target to $70 · Nov 5, 2026: Premium Brands Holdings posts Q3 2026 results · Nov 5, 2026: Prestige Consumer holds Q2 2027 earnings call